TMCnet News
Cocrystal Pharma to Present at the H.C. Wainwright Global Investment ConferenceBOTHELL, Wash., May 18, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, Chief Financial Officer and co-interim Chief Executive Officer, will present a Company overview at the H.C. Wainwright Global Investment Conference on Wednesday, May 25, 2022 at 10:00 a.m. Eastern Time. The hybrid in-person and virtual conference is being held at the Fontainebleau Miami Beach Hotel in Miami Beach. A webcast of the presentation will be available live on the IR Caendar of the Company website and will be archived for 90 days following the event. About Cocrystal Pharma, Inc. Investor Contact: Media Contact: # # # |